Last Posted: Jun 21, 2018
- The INCLUDE Project Research Plan- (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndrome)
- Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosis.
Perrone Federica et al. Neurobiology of aging 2018 May - Routine DNA Screening Moves Into Primary Care
M Andrews, NPR, May 22, 2018 - Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease.
Kauppi Karolina et al. Frontiers in neuroscience 2018 12260 - The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review.
Freudenberg-Hua Yun et al. Frontiers in medicine 2018 5108 - Whole Exome Sequencing in 20,197 Persons for Rare Variants in Alzheimer Disease
NS Raghavan et al, BioRXIV, Apr 20, 2018 - Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases.
Baldacci Filippo et al. Methods in molecular biology (Clifton, N.J.) 2018 1750139-155 - New Gene Variant Robustly Linked to Opioid Addiction
M Brooks, Medscape, Mar 2018 - “Well, good luck with that”: reactions to learning of increased genetic risk for Alzheimer disease
D Zallen, Genetics in Medicine, Mar 8, 2018 - Cognitively Healthy Individuals Want to Know Their Risk for Alzheimer's Disease: What Should We Do?
Stites Shana D et al. Journal of Alzheimer's disease : JAD 2018 62(2) 499-502
.png)
No hay comentarios:
Publicar un comentario